Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.44 USD | -6.87% |
|
-7.92% | -46.96% |
06-28 | NRx Pharmaceuticals, Inc. to Proceed with Two New Drug Applications in 2024 | CI |
06-18 | NRx Pharmaceuticals, Inc. Appoints Dennis McBride to Its Board of Directors | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-46.96% | 26.17M | |
+19.41% | 45.51B | |
-8.62% | 38.52B | |
+38.65% | 38.13B | |
+26.95% | 30.74B | |
-13.50% | 26.03B | |
+10.74% | 25.92B | |
+44.87% | 14.13B | |
+34.36% | 12.73B | |
-7.14% | 11.29B |
- Stock Market
- Equities
- BRPA Stock
- News NRx Pharmaceuticals, Inc.
- Transcript : NRx Pharmaceuticals, Inc., Q1 2023 Earnings Call, May 16, 2023